VITA 34 AG NA O.N. news, videos and press releases
For more news please use our advanced search feature.
VITA 34 AG NA O.N. - More news...
VITA 34 AG NA O.N. - More news...
- EQS-News: Vita 34 continues to show increasing revenue, improved profitability and stronger cash generation in the third quarter of 2024
- EQS-News: Vita 34 continues positive trend in the first half of 2024 and once again significantly increases operating cash flow
- EQS-Adhoc: Subsidiaries of Vita 34 reach agreement with US licensor
- EQS-News: Thomas Pfaadt appointed as new Chief Financial Officer of Vita 34 AG
- EQS-News: Vita 34 significantly increases earnings and operating cash flow in the first quarter
- EQS-News: Vita 34 returns to growth path in 2023
- EQS-Adhoc: Vita 34 closes 2023 with significantly better results than expected based on preliminary figures
- EQS-Adhoc: Vita 34 publishes preliminary figures on the course of business in 2023
- EQS-News: Vita 34 downsizes Management Board until further notice
- EQS-Adhoc: Vita 34 AG: resolves on cash capital increase under exclusion of subscription rights in the amount of up to 10% of the share capital, commitments from investors
- EQS-News: Vita 34 increases revenue and earnings in Q3 2023 and further stabilizes business development
- EQS-Adhoc: Internal investigation by Vita 34 AG reveals irregularities related to a limited number of biological samples at one of its subsidiaries regarding compliance with medical law requirements
- EQS-Adhoc: Vita 34 AG: A subsidiary of Vita 34, FamiCordTx, will file a lawsuit against a US licensor
- EQS-News: Vita 34 stabilizes business development in the second quarter and noticeably improves earnings
- EQS-News: Vita 34 successfully implements price increases in first quarter of 2023 in generally weak market environment
- EQS-News: Vita 34 Starts Recruitment for Clinical Trial with CAR-T Drug Candidate
- EQS-News: Development of Vita 34 AG in 2022 stressed by weakened consumption power of consumers along with one-off effects
- EQS-Adhoc: Vita 34 AG publishes outlook for the 2023 financial year
- EQS-Adhoc: 2022 annual result of Vita 34 AG significantly influenced by impairment of goodwill
- EQS-News: Vita 34 benefits from increasing normalization in its core business in the third quarter
- DGAP-News: Vita 34 records moderate upward trend in the second quarter
- DGAP-Adhoc: Vita 34 lowers sales and earnings guidance due to IFRS 15 effect and accelerated restructuring measures
- DGAP-News: Vita 34 introduces new Chief Financial Officer at the Annual General Meeting
- DGAP-News: Vita 34 sees first signs of stabilization in core business after war-related weaker first quarter
- DGAP-News: Vita 34 AG: Special items reflected in significant decline in earnings despite operational success in fiscal 2021
- DGAP-Adhoc: Vita 34 publishes revenue and earnings forecast for the 2022 financial year
- DGAP-Adhoc: 2021 financial figures of Vita 34 AG expected to be significantly below market expectations due to several special effects on earnings development
- DGAP-News: Vita 34 sets course for accelerated growth in new business areas with changes in the Management Board
- DGAP-Adhoc: Vita 34 AG: Change in the Chair of the Management Board
- DGAP-News: Vita 34 presents itself in new size for the first time at the Annual General Meeting 2021
